Monocytes and neutrophils from tuberculosis patients are insensitive to anti-inflammatory effects triggered by the prototypic formyl peptide N-formyl-methionyl-leucyl-phenylalanine (FMLP)

Clinical and Experimental Immunology

Volumn 133, Issue 2, 2003, Pages 267-274

  Beigier Bompadre, Macarena ^a,c   Aleman M ^a   Barrionuevo, P ^a   Franco, M C ^a   Rubel, C J ^a   Sasiain, M D C ^a   Palermo, M S ^a   Abbate, E ^b   Isturiz, M A ^a  

^a INST DE INVEST HEMATOLOGICAS   (Argentina)

^b HOSPITAL F J MUÑIZ   (Argentina)

^c ACADEMIA NACIONAL DE MEDICINA   (Argentina)

Author keywords

Formyl peptides; Leucocytes; Tuberculosis

Indexed keywords

FC RECEPTOR; FORMYLMETHIONYLLEUCYLPHENYLALANINE; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 10;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MONOCYTE; MONONUCLEAR CELL; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL; PRIORITY JOURNAL; TUBERCULOSIS;

CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; MALE; MONOCYTES; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; REACTIVE OXYGEN SPECIES; RECEPTORS, IGG; TUBERCULOSIS, PULMONARY; UP-REGULATION;

EID: 0043168027     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02212.x     Document Type: Article

References (31)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance Monitoring Project. JAMA 1999; 282:677-86.
2. Ottenhof TH, Kumararatne D, Casanova JL. Novel human immunodeficiency reveal the essential role of type-1 cytokines in immunity to intracellular bacteria. Immunol Today 1998; 19:491-4.
3. Ting LM, Kim AC, Cattamanchi A, Ernst JD. Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. J Immunol 1999; 163:3898-906.
4. Ellner JJ. The human response in tuberculosis. J Infect Dis 1997; 176:1351-9.
5. Chun T, Serbina NV, Nolt D et al. Induction of M3-restricted cytotoxic T lymphocyte responses by N-formylated peptides derived from Mycobacterium tuberculosis. J Exp Med 2001; 1993:1213-20.
6. Snyderman R, Pike MC. Chemoattractant receptors on phagocytic cells. Annu Rev Immunol 1984; 2:257-81.
7. Rot A, Henderson LE, Copeland TD, Leonard EJ. A series of six ligands for the human formyl peptide receptor: tetrapeptides with high chemotactic potency and efficacy. Proc Natl Acad Sci USA 1987; 84:7967-71.
8. Beigier-Bompadre M, Barrionuevo P, Alves-Rosa F, Rubel C, Palermo M, Isturiz MA. N-Formyl-methionyl-leucyl-phenylalanine (FMLP) inhibits the interferon-γ and interleukin-10 induced expression of FcγRI on human monocytes. Clin Diagn Lab Immunol 2001; 8:402-8.
9. Alves-Rosa MF, Vulcano M, Beigier M, Breyer I, Isturiz MA. The down-regulation of FcγRII and FcγRIIB by N-formyl-methionyl-leucyl-phenylalanine (FMLP) depends on secretory events in human neutrophils. Immunol Lett 1999; 70:119-26.
10. Alves-Rosa MF, Vulcano M, Minucci F, di Gianni P, Isturiz MA. Inhibition of FcγR-dependent functions by N-formyl-methionyl-leucyl-phenylalanine in human neutrophils. Clin Exp Immunol 1997; 83:147-55.
11. Hussain R, Dawood G, Abrar N, Toossi Z, Minai A, Dojki M, Ellner J. Selective increases in antibody isotypes and immunoglobulin G subclass responses to secreted antigens in tuberculosis patients and healthy household contacts of the patients. Clin Diagn Lab Immunol 1995; 2:726-32.
12. Hussain R, Shiratsuchi H, Ellner J, Wallis RS. PPD-specific IgG1 antibody subclass upregulate tumour necrosis factor expression in PPD-stimulated monocytes: possible link with disease pathogenesis in tuberculosis. Clin Exp Immunol 2000; 119:449-55.
13. Hussain R, Shiratsuchi H, Phillips M, Ellner J, Wallis RS. Opsonizing antibodies (IgG1) up-regulate monocyte proinflammatory cytokines tumour necrosis factor-alpha (TNF-alpha) and IL-6 but not anti-inflammatory cytokine IL-10 in mycobacterial antigen-stimulated monocytes - implications for pathogenesis. Clin Exp Immunol 2001; 123:210-8.
14. Vanham G, Edmonds K, Qing L et al. Generalized immune activation in pulmonary tuberculosis: co-activation with HIV infection. Clin Exp Immunol 1996; 103:30-4.
15. Boyum A. Separation of leukocytes from blood and bone marrow. Scand J Lab Invest 1968; 22:77-89.
16. Jarstrand C. The NBT (nitroblue tetrazolium) activity of neutrophil granulocytes in patients with influenza A infection. Scand J Infect Dis 1977; 9:5-7.
17. Perussia B, Dayton ET, Lazarus R, Fanning V, Trinchieri G. Immune interferon induces the receptor for monomeric IgG1 on human monocytic and myeloid cells. J Exp Med 1983; 158:1092-113.
18. Andersson A, Dai WJ, Di Santo JP, Brombacher F. Early IFN-gamma production and innate immunity during Listeria rnonocytogenes infection in the absence of NK cells. J Immunol 1998; 161:5600-6.
19. Beigier-Bompadre M, Barrionuevo P, Alves-Rosa F, Rubel CJ, Palermo MS, Isturiz MA. The formyl peptide N-formyl-methionyl-leucyl-phenylalanine (FMLP) downregulates the expression of FcγRs in IFN-γ-activated monocytes/macrophages in vitro and in vivo. Scand J Immunol 2003; 57:221-8.
20. Appelberg R. Mycobacterial infection primes T cells and macrophages for enhanced recruitment of neutrophils. J Leukoc Biol 1992; 57:472-7.
21. Appelberg R, Silva MT. T cell-dependent chronic neutrophilia during mycobacterial infections. Clin Exp Immunol 1989; 78:478-83.
22. Pedrosa J, Saunders BM, Appelberg R, Ormie IM, Silva MT, Cooper AM. Neutrophils play a protective role in Mycobacterium tuberculosis infection in mice. Infect Immun 2000; 68:577-83.
23. Alemán M, Beigier-Bompadre M, Borghetti C et al. Activation of peripheral blood neutrophils from patients with active advanced tuberculosis. Clin Immunol 2001; 100:87-95.
24. Elbim C, Prevot MH, Bouscarat F, Franzini E, Chollet-Martin S, Hakim J, Gougerot-Pocidalo MA. Polymorphonuclear neutrophils from human immunodeficiency virus-infected patients show enhanced activation, diminished fMLP-induced 1-selectin shedding, and an impaired oxidative burst after cytokine priming. Blood 1994; 84:2759-66.
25. Lin Y, Zhang M, Hofman FM, Gong J, Barnes PF. Absence of a prominent TH2 cytokine response in human tuberculosis. Infect Immun 1996; 64:1351-6.
26. Lin Y, Zhang M, Hofman FM, Gong J, Abrams JS, Barnes PF. T cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun 1995; 63:3231-4.
27. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001; 19:93-129.
28. Gong J-H, Zhang M, Modlin RL et al. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA4 expression. Infect Immun 1996; 64:913-8.
29. Boussiotis VA, Tsai EY, Yunis EJ et al. IL-10-producing T cells supress immune responses in anergic tuberculosis patients. J Clin Invest 2000; 105:1317-25.
30. Förtsch D, Röllinghoff M, Stenger S. IL-10 converts human dendritic cells into macrophage-like cells with increased antibacterial activity against virulent Mycobacterium tuberculosis. J Immunol 2000; 165:978-87.
31. Vulcano M, Alves-Rosa MF, Minnucci FS, Chernavsky AC, Isturiz MA. N-formyl-methionyl-leucyl-phenylalanine (fMLP) inhibits tumour necrosis factor-alpha (TNF-alpha) production on lipopolysaccharide (LPS) -stimulated human neutrophils. Clin Exp Immunol 1998; 113:39-47.